Abstract
We present a case of a chronic mass-forming pancreatitis (CMFP) detected by 18F-choline (FCH) PET/CT in a male affected by prostate cancer. FCH PET/CT scan showed a focal uptake in the uncinate process of the pancreas, later diagnosed as a CMFP at biopsy. Although the physiological distribution of FCH in the pancreas, a careful interpretation of the images in this area is warranted.
Highlights
An Incidental Pancreatic Finding at 18F-Choline PET/CT: ChIAnrtenoresntIinnigcIcmiaMdgeseanstasl-FPoanrmcreinatgicPFainndcirnegataitti1s8F‐Choline PET/CT: LaurCa EhvraongneliicstaM1,*as, Asl‐eFssoanrdmroiDnegPePlleagnrincr2,eRaotsisatniso Girometti 3,4, Gianluca Cassarino 1, Francesco Giacomuzzi 5 and Marco Rensi 5
In many cancers and in the immune cells as macrophages, present in inflammatory processes [9,10,11]. This is the first case of CMFP detected by FCH
We cannot recommend the use of FCH PET as an alternative diagnostic imaging in autoimmune pancreatic processes, but we strongly suggest careful interpreting PET-imaging
Summary
An Incidental Pancreatic Finding at 18F-Choline PET/CT: ChIAnrtenoresntIinnigcIcmiaMdgeseanstasl-FPoanrmcreinatgicPFainndcirnegataitti1s8F‐Choline PET/CT: LaurCa EhvraongneliicstaM1,*as, Asl‐eFssoanrdmroiDnegPePlleagnrincr2,eRaotsisatniso Girometti 3,4 , Gianluca Cassarino 1, Francesco Giacomuzzi 5 and Marco Rensi 5. Laura Evangelista 1,*, Alessandro De Pellegrin 2, Rossano Girometti 3,4, Gianluca Cassarino 1, Francesco Giacomuzzi 5 and M1 arNcuocRleeanr sMi e5dicine Unit, Department of Medicine DIMED, University of Padova, 35128 Padova, Italy; giancassa@hotmail.it MUanriviaerdsietlylaofMPaisdeorvicao, 3r5d1i2a8, 3P3a1d0o0vaU, Idtailnye; , Italy; giaalnecsassasna@dhroot.dmeapile.iltlegrin@asufc.sanita.fvg.it Maria della Misericordia, 33100 Udine, Italy; 5 NFurcalenacreMsceod.igcinaecoUmniut,zUzin@ivaesrusiftcy.sHaonsiptait.aflvSg..Mit a(Fri.aGd.)e;llma Maricsoer.riceonrsdii@a,a3s3u1f0c0.sUadniintae,.fIvtagly.i;t (M.R.)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
